Literature DB >> 4155973

Investigations on the mode of action of ergotamine in the isolated femoral vein of the dog.

E Müller-Schweinitzer, E Stürmer.   

Abstract

1 Experiments on spiral strips cut from the femoral vein of dogs suspended in Krebs-Henseleit solution were carried out.2 Ergotamine caused stimulation in concentrations about 350 times lower than noradrenaline (ED(50) of ergotamine = 2.2 x 10(-9) M; ED(50) of noradrenaline = 7.6 x 10(-7) M), but the maximal responses to ergotamine were only about one third those to noradrenaline.3 The pA(2) value of ergotamine against noradrenaline was 8.8.4 The effects of ergotamine can be blocked by prior administration of phentolamine. The pA(2) value for phentolamine against ergotamine was 6.8 and the pA(2) value for phentolamine against noradrenaline was 7.5.5 It is concluded that the stimulant action of ergotamine on smooth vascular muscle probably is mediated mainly via alpha-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4155973      PMCID: PMC1776770          DOI: 10.1111/j.1476-5381.1974.tb10680.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters.

Authors:  J M VAN ROSSUM
Journal:  Arch Int Pharmacodyn Ther       Date:  1963

2.  Dibenamine blockade in strips of rabbit aorta and its use in differentiating receptors.

Authors:  R F FURCHGOTT
Journal:  J Pharmacol Exp Ther       Date:  1954-07       Impact factor: 4.030

3.  On some physiological actions of ergot.

Authors:  H H Dale
Journal:  J Physiol       Date:  1906-05-31       Impact factor: 5.182

4.  The effect of ergotamine on humoral and neuronal actions in the nictitating membrane and the spleen of the cat.

Authors:  R Salzmann; W Pacha; M Taeschler; H Weidmann
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

5.  Direct agonistic and antagonistic effects of ergotamine on vertebrate melanophores.

Authors:  J M Goldman; M E Hadley
Journal:  Arch Int Pharmacodyn Ther       Date:  1970-02

6.  Adrenergic receptors in the veins of the dog.

Authors:  S Guimarães; W Osswald
Journal:  Eur J Pharmacol       Date:  1969-01       Impact factor: 4.432

7.  Influence of propranolol and ICI 50,172 on the cardiovascular actions of catecholamines as modified by ergotamine.

Authors:  W Osswald; S Guimarães; J Garrett
Journal:  J Pharmacol Exp Ther       Date:  1970-08       Impact factor: 4.030

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03
  8 in total
  11 in total

1.  Effects of lysergic acid diethylamide on autonomic post-ganglionic transmission.

Authors:  N Ambache; S W Killick; V Srinivasan; M A Zar
Journal:  J Physiol       Date:  1975-04       Impact factor: 5.182

2.  Lack of effect of dihydroergotamine on endothelial and smooth muscle cell proliferation and endothelial cell prostanoid production.

Authors:  B Lindblad; W E Burkel; T W Wakefield; L M Graham; J C Stanley
Journal:  Experientia       Date:  1988-03-15

3.  Responsiveness of isolated canine cerebral and peripheral arteries to ergotamine.

Authors:  E Müller-Schweinitzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

4.  The influence of dihydroergotamine on adenosine-induced and reactive coronary vasodilation. Interaction of dihydroergotamine and coronary vasodilation.

Authors:  G Raberger; W Schütz; M Zimpfer; O Kraupp
Journal:  Basic Res Cardiol       Date:  1976 Nov-Dec       Impact factor: 17.165

5.  Evidence for stimulation of 5-HT receptors in canine saphenous arteries by ergotamine.

Authors:  E Müller-Schweinitzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-10       Impact factor: 3.000

Review 6.  Pharmacology of bromocriptine in health and disease.

Authors:  A E Mehta; G Tolis
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

7.  Mechanisms of the ergonovine-induced vasoconstriction in the rabbit main coronary artery.

Authors:  A Suyama; H Kuriyama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-07       Impact factor: 3.000

8.  The effect of ergotamine on tissue blood flow and the arteriovenous shunting of radioactive microspheres in the head.

Authors:  B M Johnston; P R Saxena
Journal:  Br J Pharmacol       Date:  1978-07       Impact factor: 8.739

9.  Ergotamine abuse and extra-hepatic portal hypertension.

Authors:  P E Fisher; D B Silk; N Menzies-Gow; M Dingle
Journal:  Postgrad Med J       Date:  1985-05       Impact factor: 2.401

10.  Vasoactivity and Vasoconstriction Changes in Cattle Related to Time off Toxic Endophyte-Infected Tall Fescue.

Authors:  James L Klotz; Glen E Aiken; Jessica R Bussard; Andrew P Foote; David L Harmon; Ben M Goff; F Neal Schrick; James R Strickland
Journal:  Toxins (Basel)       Date:  2016-09-22       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.